The lawsuit claims both Novo Nordisk, the manufacturer of Ozempic, and Eli Lilly, the manufacturer of Mounjaro, both knew, or should have known, that the drugs increase the risk of gastroparesis and gastroenteritis that can lead to severe side effects such as nausea, vomiting undigested food, abdominal pain, abdominal bloating, severe dehydration, feeling full after only a few bites, undigested food hardening in the stomach, acid reflux, fluctuating blood sugar levels, lack of appetite, weight loss, malnutrition and decreased quality of life
Agonistas duales GIP/GLP-1
Sample Meal Plan Maintaining a balanced diet is crucial for overall health
Factors such as adherence to the medication, individual metabolism, and lifestyle choices all influence the timeline for visible results
It is nicknamed the "Wolverine stack" in online communities because both compounds have been associated with faster tissue-repair markers in preclinical work